Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-008785
Filing Date
2025-03-21
Accepted
2025-03-21 16:51:12
Documents
1
Period of Report
2025-03-20

Document Format Files

Seq Description Document Type Size
1 form4-03212025_080309.html 4  
1 form4-03212025_080309.xml 4 4241
  Complete submission text file 0001415889-25-008785.txt   5746
Mailing Address 749 N MARY AVE SUNNYVALE CA 94085
Business Address
GRYSKA DAVID W (Reporting) CIK: 0001202335 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 25761293

Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)